Author: Inchingolo, Riccardo; Pierandrei, Chiara; Montemurro, Giuliano; Smargiassi, Andrea; Lohmeyer, Franziska Michaela; Rizzi, Angela
Title: Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review Cord-id: jvkv4eia Document date: 2021_3_20
ID: jvkv4eia
Snippet: Non-cystic fibrosis bronchiectasis is a chronic disorder in which immune system dysregulation and impaired airway clearance cause mucus accumulation and consequent increased susceptibility to lung infections. The presence of pathogens in the lower respiratory tract causes a vicious circle resulting in impaired mucociliary function, bronchial inflammation, and progressive lung injury. In current guidelines, antibiotic therapy has a key role in bronchiectasis management to treat acute exacerbation
Document: Non-cystic fibrosis bronchiectasis is a chronic disorder in which immune system dysregulation and impaired airway clearance cause mucus accumulation and consequent increased susceptibility to lung infections. The presence of pathogens in the lower respiratory tract causes a vicious circle resulting in impaired mucociliary function, bronchial inflammation, and progressive lung injury. In current guidelines, antibiotic therapy has a key role in bronchiectasis management to treat acute exacerbations and chronic infection and to eradicate bacterial colonization. Contrastingly, antimicrobial resistance, with the risk of multidrug-resistant pathogen development, causes nowadays great concern. The aim of this literature review was to assess the role of antibiotic therapy in bronchiectasis patient management and possible concerns regarding antimicrobial resistance based on current evidence. The authors of this review stress the need to expand research regarding bronchiectasis with the aim to assess measures to reduce the rate of antimicrobial resistance worldwide.
Search related documents:
Co phrase search for related documents- acute exacerbation and long term exacerbation: 1, 2, 3, 4, 5
- acute exacerbation and long term oxygen therapy: 1
- acute exacerbation and long term treatment: 1
- acute exacerbation and low quality: 1, 2, 3
- acute exacerbation and low quality evidence: 1, 2
- acute exacerbation and lung damage: 1, 2, 3, 4
- acute exacerbation and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- acute exacerbation and lung function change: 1
- acute exacerbation and lung function decline: 1, 2
- acute exacerbation and lung function deterioration: 1
- acute exacerbation and lung infection: 1, 2, 3
- acute exacerbation and lung transplantation: 1, 2
Co phrase search for related documents, hyperlinks ordered by date